SurModics

Surmodics and Abbott’s Drug-Coated Balloon for Peripheral Artery Disease Gets FDA Approval
Surmodics and Abbott’s Drug-Coated Balloon for Peripheral Artery Disease Gets FDA Approval
Xtalks
Medtech
SurModics
Abbott Labs
peripheral artery disease
FDA
SurVeil
drug-coated balloons
Flag link:
Surmodics Takes a Second Swing at FDA Approval
Surmodics Takes a Second Swing at FDA Approval
Medical Devices and Diagnostics Industry
SurModics
Medtech
SurVeil
drug-coated balloons
FDA
Flag link:
Abbott Could Potentially Dump SurVeil Commercialization Plans
Abbott Could Potentially Dump SurVeil Commercialization Plans
Medical Devices and Diagnostics Industry
Medtech
devices
Abbott Labs
SurVeil
SurModics
Flag link:
FDA demands additional data on Abbott rival to Medtronic balloon, setting back approval timeline
FDA demands additional data on Abbott rival to Medtronic balloon, setting back approval timeline
Medtech Dive
FDA
Medtech
devices
Abbott Labs
SurModics
Medtronic
SurVeil
drug-coated balloons
Flag link:
10 of the Most Anticipated New Medical Devices
10 of the Most Anticipated New Medical Devices
Medical Devices and Diagnostics Industry
devices
Medtech
Senseonics
Eversense XL
Insulet
Omnipod 5
Globus Medical
xcelsius 3D Imaging System
Glaukos
iStent Infinite
DexCom
G7
Zimmer Biomet
Persona IQ
Abbott Labs
Amulet
Evo Visian
Medtronic
Guardian 4
SurModics
SurVeil
Flag link:
Surmodics' Regulatory Win Marks a Positive Shift in Paclitaxel Controversy
Surmodics' Regulatory Win Marks a Positive Shift in Paclitaxel Controversy
Medical Devices and Diagnostics Industry
SurModics
SurVeil
Europe
paclitaxel
devices
Flag link:
SurModics Beats on All Fronts
SurModics Beats on All Fronts
Yahoo/Zacks
SurModics
Flag link:
SurModics Reports Second Quarter Fiscal Year 2012 Results
SurModics Reports Second Quarter Fiscal Year 2012 Results
SurModics
earnings
Flag link:
SurModics Completes Sale of Pharmaceutical Assets
SurModics Completes Sale of Pharmaceutical Assets
SurModics
sale
Flag link:
SurModics' CEO Discusses F4Q 2011 Results - Earnings Call Transcript
SurModics' CEO Discusses F4Q 2011 Results - Earnings Call Transcript
SurModics
CEO
earnings
Flag link:
SurModics cutting 9% of workforce in realignment
SurModics cutting 9% of workforce in realignment
SurModics
job cuts
layoffs'
Flag link:
SurModics Disappoints in Q4
SurModics Disappoints in Q4
Yahoo/Zacks
SurModics
earnings
Flag link:
SurModics and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product
SurModics and Edge Therapeutics Collaborate on Development of Sustained-Release Neurological Product
SurModics
Edge Therapeutics
NimoGel
EG-1961
cerebral ischemia
subarachnoid hemorrhage
Flag link:
SurModics Beats
SurModics Beats
Yahoo/Zacks
SurModics
Flag link: